Protheragen Debuts Microbiota Research Service for Obesity

Nov 20, 2026

United States, November 20, 2026 /MarketersMEDIA/ -- Protheragen, a specialized Contract Research Organization (CRO) dedicated to preclinical obesity research, today announced the launch of its Obesity Microbiota Research Service, an end-to-end research solution designed to examine the relationship between gut microbiota and obesity. The service encompasses animal model development, sample collection, 16S rRNA gene sequencing and/or shotgun metagenomic sequencing, and advanced bioinformatics and analytics. Leveraging research in obesity, microbiomics, and systems biology, the service focuses on identifying and prioritizing microbial targets that can aid in the development of next-generation anti-obesity therapeutics for biotechnology and pharmaceutical companies.

Research indicates that imbalances in gut microbial populations can influence the development of metabolic disorders and obesity, and ongoing work aims to elucidate the mechanisms by which these microbial populations contribute to obesity and to develop therapeutic strategies that modulate them. Protheragen's Obesity Research Platform provides biotechnology and pharmaceutical companies with an integrated system to perform preclinical research on obesity and related disorders, facilitate the identification of therapeutic targets, and support the development of personalized microbiome-modulating strategies.

The Obesity Microbiota Research Service standardizes and streamlines its processes to provide clients with reproducible data. Once an appropriate animal model (e.g., mice or rats) is selected, the service can induce obesity using various means, including dietary manipulations, environmental modifications, and genetic manipulations. After sample collection (e.g., blood, feces, and intestinal tissues), the service provides specialized processing to protect the microbial contents and increase the precision of analysis. The service uses various techniques—including 16S rRNA gene sequencing, metagenomics, and metabolomics—to characterize microbial components and their metabolites, and to elucidate their effects on host physiology. Various bioinformatics and statistical tools are used to analyze the data and draw conclusions regarding the functional capabilities of the microbial components and their roles in obesity. This service provides clients with the ability to understand functionally important microbial components and groups, identify dysbiotic microbiota associated with obesity, and support the development of microbiota-based therapies for obesity.

Beyond microbiota-focused studies, the Obesity Microbiota Research Service is part of the broader Obesity Research Platform, which supports the entire spectrum of anti-obesity therapeutic development—including small-molecule drugs that modulate the gut microbiota, gene and cell therapies, antibody therapies, tissue engineering, and other transformative approaches. Rigorous preclinical validation is conducted to provide scientific justification for advancing a therapeutic candidate to clinical trials. Each candidate undergoes pharmacodynamic and pharmacokinetic studies, toxicological evaluation, and safety assessment, with bioanalytical support provided throughout.

About Protheragen

Protheragen is a specialized Contract Research Organization (CRO) dedicated to advancing preclinical research in obesity. Driven by a passion for scientific innovation and a commitment to client success, the company has established a reputation for delivering high-quality data, actionable insights, and tailored solutions that drive breakthroughs in obesity therapeutics. Its integrated Obesity Research Platform seamlessly combines expertise across metabolism, inflammation, and cardiovascular biology, enabling a holistic approach to obesity research and therapy development. The company maintains quality control standards throughout its preclinical services to support the integrity and regulatory acceptance of generated data. For more information about the Obesity Microbiota Research Service, please contact Protheragen.

Contact Info:
Name: Anna White
Email: Send Email
Organization: Protheragen
Website: https://www.obesityscientific.com/

Release ID: 89210336

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.

More News

article.head.headline
Nov 20, 2026
Airbnb's divisive new house rules come into force

New rules on what Airbnb hosts can reasonably ask guests to do could mean fewer chores but higher costs for customers.

article.head.headline
Nov 20, 2026
Anthropic shares fall a day after blockbuster opening

Other tech companies have also taken a hit as share markets broadly slump.

article.head.headline
Nov 20, 2026
Could you spot a fake banknote?

A landlord says he took £100 in fake banknotes during his pub's opening weekend.

article.head.headline
Nov 20, 2026
Anthropic Shares Slip as AI and Tech Stock Sell-Off Continues

The S&P 500 and Nasdaq were on course for their worst weekly performances in over a year. Anthropic’s shares tumbled as much as 8 percent when U.S. markets opened on Friday.

article.head.headline
Nov 20, 2026
Judge Allows Trump’s Case Against The Times to Proceed

Mr. Trump accused the news organization and the book publisher Penguin Random House of disparaging his reputation as a successful businessman.

article.head.headline
Nov 20, 2026
The secret cyber scramble to protect UK fridge freezers

A behind the scenes cyber-security operation has taken place to secure tens of thousands of refrigeration units from hackers, the BBC has learned.

article.head.headline
Nov 20, 2026
C.F.T.C. Officials Considered Investigating Trump’s Memecoin, Then Punted

Lawyers at the Commodity Futures Trading Commission looked into possible fraud soon after the digital token’s launch, then decided they would not get the commission’s support.

article.head.headline
Nov 20, 2026
Thousands join cost of living protests across Europe

Student-led protests have swept across Europe in response to the rising cost of living, housing shortages and underfunded education.

article.head.headline
Nov 20, 2026
Should You Invest in Anthropic? Here’s What to Consider.

Placing a meaningful portion of your wealth on a single stock is never a good idea, but if you feel tempted to invest, ask yourself several questions first.

article.head.headline
Nov 20, 2026
Turkey’s Van Cats Contend With Rising Temperatures

A feline research center uses air-conditioning and pools to keep residents comfortable as their numbers recover. And yes, they like to swim.

article.head.headline
Nov 20, 2026
Savings Bonds Offer Enticing Rates. You Need to Prove Your Identity First.

The Treasury Department is working with a private service, ID.me, to grant access to the TreasuryDirect website. Some users reported trouble getting in.

article.head.headline
Nov 20, 2026
GTA 6 drives spike in download demand, as estimated sales top $2.3bn

Rockstar Games ended a 13-year wait with what is expected to be the biggest entertainment launch ever.


YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.